About 90% of the global mortality was in the northerly latitudes, above roughly 30 degrees north
Once touted as a 'wonder drug', HCQ has been battling global controversies around its safety and efficacy as a prophylactic against the new coronavirus SARS-CoV-2.
From patients struggling to find hospital beds, to the crisis moving to India's rural areas, and what a new study says about hydroxychloroquine - read these and more in today's India dispatch
Based on this development, we can no longer vouch for the veracity of the primary data sources, the retraction statement noted
HCQ was dropped from the solidarity trial that WHO was conducting as a part of a global effort in May.
Almost 90 per cent of the participants, according to the study, reported a high-risk exposure to a confirmed Covid-19 contact
From how Prince Charles 'got away lightly', to cheap beach holidays targetting locals, and why Africa has to weather the storm without massive stimulus - read these and more in today's world dispatch
Hydroxychloroquine did not seem to cause serious harm but was no better than placebo pills, says medical journal.
The World Health Organization said Wednesday that it will resume recruiting patients for the hydroxychloroquine arm of a global trial called Solidarity.
According to the National Task Force for Covid-19 in India recommended once a week maintenance dose for seven weeks (400 mg once weekly), following the loading dose (400 mg bd)
A spokeswoman for Mandeep R Mehra, the Harvard professor who was the paper's lead author, said on Friday that the study's authors had asked for an independent academic review and audit of their work.
It also stated that the decision of WHO to temporarily suspend quality HCQ trials based on findings of the Lancet study appears to be a "knee-jerk reaction"
They must be worn and taken off properly to ensure any contaminated surfaces don't touch the face, and if reusable, washed regularly
The decision came a day after French health organisations, namely, the HCSP health advisory and ANSM drugs agency, advised against using hydroxychloroquine for Covid-19 treatment
Indian researchers have not found any major side-effects of HCQ and its use should be continued in preventive treatment for Covid-19, ICMR said
From Kerala's smart testing and community care, to hospitals putting off elective surgeries, and the progress with solidarity trials so far - read these and more in today's India dispatch
Primary responsibility for containing the virus is now with society
The Health Ministry is centrally procuring HCQ (200mg to be used in proportionality in lieu of 400 mg tablets) and distributing to the states/UTs through government medical store depot in New Delhi
Confirmed cases surge past 145,000; fatality rate down from 3.3% to 2.87%
Let's take a look at major coronavirus related developments in India and elsewhere